2Hande K R. Etoposide:four decades of development of a topoisomerase Ⅱ inhibitor[J]. Eur J Cancer, 1998,34:1 514- 1 521.
3Bicknell G R. Snowden R T,Cohen G M. Formation of high molecular mass DNA fragmentation is a marker of apoptosis in the human leukemia cell line U937[J]. J Cell Sci, 1994,107: 2 483-2488.
6LILIEMARK E, SJOSTROM B, LILIEMARK J,et al. Targeting of teniposide to the mononuclear phagocytic system (MPS) by incorporation in liposomes and submicron lipid particles;an autoradiographic study in mice [ J]. Leuk Lymphoma, 1995,18 (1-2) : 113 -118.
7LILIEMARK E, LILIEMARK J, KALLBERG N,et al. Studies of the organ distribution in mice of teniposide liposomes designed for treatment of diseases in the monomuclear phagocytic system[ J]. Pediatr Res, 1995,38 ( 1 ) :7 - 10.
8替尼泊苷注射液新药转正标准WSI-(X-338)-2003Z,X45-57[s].2003.
9Wadhwa L,Hurwitz MY,Chévez-Barrios P,et al.Treat-ment of invasive retinoblastoma in a murine model using an oncolytic picornavirus[J].Cancer Res,2007,67(22):10653-10656.
10Kim JW,Abramson DH,Dunkel IJ.Current management strategies for intraocular retinoblastoma[J].Drugs,2007,67(15):2173-2185.
